Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of CALCITRAN B12 patients who developed OSTEOPENIA.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking CALCITRAN B12 reported OSTEOPENIA to the FDA. A total of 2 CALCITRAN B12 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CALCITRAN B12 and OSTEOPENIA. In doing so, we compare CALCITRAN B12 with other drugs that cause OSTEOPENIA, to help you evaluate whether or not CALCITRAN B12 causes OSTEOPENIA. Likewise, this page shows the most highly-reported side effects of CALCITRAN B12, so you can see if OSTEOPENIA ranks among CALCITRAN B12's most well-known side effects.
Summary Statistics
Reports of CALCITRAN B12 causing OSTEOPENIA: 1
Reports of any side effect of CALCITRAN B12 : 2
Percentage of CALCITRAN B12 patients where OSTEOPENIA is a reported side effect: 50.0000%

FDA reports of any drug causing OSTEOPENIA : 6844
Average percentage for all medicated patients where OSTEOPENIA is reported as a complication: 0.0429%

Physician opinion on CALCITRAN B12 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CALCITRAN B12:
OSTEOPOROSIS PROPHYLAXIS ( 1 patients )
VITAMIN SUPPLEMENTATION ( 1 patients )
Drugs with high FDA adverse event association with OSTEOPENIA:

FOSAMAX (4783 patients)
ZOMETA (2152 patients)
AREDIA (1754 patients)
ASPIRIN (1199 patients)
PREDNISONE (1006 patients)
ACCUTANE (847 patients)
NEXIUM (804 patients)
VIOXX (786 patients)
PRILOSEC (776 patients)
COUMADIN (661 patients)
DECADRON (640 patients)
AMBIEN (582 patients)
SYNTHROID (573 patients)
PREMARIN (558 patients)
CELEBREX (557 patients)
LIPITOR (553 patients)
LASIX (521 patients)
NEURONTIN (520 patients)
LEVAQUIN (482 patients)
PROTONIX (474 patients)
OXYCONTIN (457 patients)
ALENDRONATE SODIUM (455 patients)
DEXAMETHASONE (450 patients)
THALIDOMIDE (446 patients)
PERCOCET (438 patients)
VICODIN (422 patients)
FOLIC ACID (411 patients)
LISINOPRIL (410 patients)
ZOLOFT (407 patients)
ARIMIDEX (402 patients)
CALCIUM (393 patients)
ZOFRAN (392 patients)
CHEMOTHERAPEUTICS NOS (386 patients)
ATIVAN (380 patients)
MULTI-VITAMINS (372 patients)
CLINDAMYCIN (370 patients)
VITAMIN D (370 patients)
ZOCOR (369 patients)
OXYCODONE HCL (361 patients)
XANAX (355 patients)
PREVACID (355 patients)
ACETAMINOPHEN (354 patients)
AMOXICILLIN (342 patients)
ATENOLOL (341 patients)
FEMARA (341 patients)
ACTONEL (339 patients)
TAMOXIFEN CITRATE (335 patients)
COMPAZINE (328 patients)
FUROSEMIDE (326 patients)
ALBUTEROL (325 patients)
FOSAMAX PLUS D (322 patients)
FLEXERIL (314 patients)
PAXIL (306 patients)
CALCIUM (UNSPECIFIED) (305 patients)
MORPHINE (303 patients)
HYDROCHLOROTHIAZIDE (301 patients)
TOPROL-XL (295 patients)
OMEPRAZOLE (294 patients)
PREDNISONE TAB (292 patients)
DILAUDID (289 patients)
LORTAB (287 patients)
POTASSIUM CHLORIDE (285 patients)
NORVASC (280 patients)
METHOTREXATE (279 patients)
CYTOXAN (279 patients)
ZITHROMAX (278 patients)
LORAZEPAM (276 patients)
PREMPRO (276 patients)
PERIDEX (275 patients)
LOVENOX (274 patients)
REVLIMID (272 patients)
GABAPENTIN (269 patients)
LEXAPRO (267 patients)
IBUPROFEN (265 patients)
CALCIUM CARBONATE (263 patients)
ALLEGRA (261 patients)
COLACE (259 patients)
CHLORHEXIDINE GLUCONATE (256 patients)
ARANESP (255 patients)
ZANTAC (254 patients)
CIPROFLOXACIN (253 patients)
PROZAC (251 patients)
SIMVASTATIN (246 patients)
PLAVIX (245 patients)
BONIVA (244 patients)
CELEXA (242 patients)
KEFLEX (240 patients)
FLAGYL (239 patients)
EVISTA (234 patients)
ASCORBIC ACID (231 patients)
REGLAN (231 patients)
CYMBALTA (228 patients)
AUGMENTIN '125' (223 patients)
RADIATION THERAPY (222 patients)
VITAMIN E (220 patients)
ZYRTEC (219 patients)
ALLOPURINOL (216 patients)
LYRICA (215 patients)
FLONASE (213 patients)
ADRIAMYCIN PFS (213 patients)
VITAMIN D (UNSPECIFIED) (212 patients)
PROCRIT /00909301/ (210 patients)
EPOGEN (209 patients)
PEPCID (209 patients)
PROVERA (208 patients)
FASLODEX (207 patients)
AROMASIN (206 patients)
XELODA (205 patients)
TAXOTERE (204 patients)
DOXYCYCLINE (204 patients)
VANCOMYCIN (201 patients)
ADVAIR DISKUS 100/50 (198 patients)
MS CONTIN (197 patients)
DIFLUCAN (197 patients)
NITROGLYCERIN (197 patients)
WARFARIN SODIUM (196 patients)
CEPHALEXIN (195 patients)
VELCADE (194 patients)
ACYCLOVIR (193 patients)
DIOVAN (193 patients)
VITAMINS (UNSPECIFIED) (191 patients)
RANITIDINE (189 patients)
SEROQUEL (188 patients)
TAXOL (178 patients)
DIGOXIN (178 patients)
LOPRESSOR (178 patients)
DURAGESIC-100 (177 patients)
HYDROCORTISONE (176 patients)
BACTRIM (175 patients)
SINGULAIR (174 patients)
CIPRO (174 patients)
VINCRISTINE (174 patients)
MELPHALAN HYDROCHLORIDE (172 patients)
NYSTATIN (170 patients)
ESTRADERM (170 patients)
PROMETHAZINE (167 patients)
FISH OIL (166 patients)
AVELOX (166 patients)
POTASSIUM (165 patients)
FENTANYL (163 patients)
KLONOPIN (162 patients)
DEPO-PROVERA (162 patients)
COZAAR (160 patients)
ROCEPHIN (160 patients)
MULTIVITAMIN ^LAPPE^ (158 patients)
IRON (157 patients)
LEVOTHYROXINE SODIUM (156 patients)
EFFEXOR (155 patients)
VALIUM (155 patients)
TYLENOL-500 (152 patients)
MEGACE (152 patients)
TYLENOL (150 patients)
REMICADE (148 patients)
FLUCONAZOLE (148 patients)
HYDROCODONE BITARTRATE (148 patients)
ALKERAN (148 patients)
PRAVACHOL (147 patients)
TRAZODONE HCL (147 patients)
DARVOCET-N 50 (146 patients)
OXYCODONE (146 patients)
ALPRAZOLAM (145 patients)
AVONEX (144 patients)
METRONIDAZOLE (140 patients)
ENBREL (139 patients)
FERROUS SULFATE TAB (139 patients)
ACIPHEX (137 patients)
NEUPOGEN (135 patients)
MIACALCIN (134 patients)
VITAMIN B6 (134 patients)
GLUCOSAMINE (130 patients)
ELAVIL (130 patients)
FLOMAX (130 patients)
MIRALAX (129 patients)
CLARITIN (129 patients)
HERCEPTIN (129 patients)
DIAZEPAM (128 patients)
CARDIZEM (127 patients)
MOBIC (127 patients)
AMITRIPTYLINE HCL (127 patients)
DARVOCET-N 100 (127 patients)
LOMOTIL (127 patients)
METOPROLOL TARTRATE (124 patients)
BEXTRA (122 patients)
VALTREX (122 patients)
FORTEO (122 patients)
HYDROCODONE (120 patients)
MORPHINE SULFATE (120 patients)
ZETIA (120 patients)
AVASTIN (118 patients)
[THERAPY UNSPECIFIED] (117 patients)
NAPROXEN (117 patients)
PENICILLIN VK (117 patients)
KLOR-CON (115 patients)
PENICILLIN ^GRUNENTHAL^ (114 patients)
TRAMADOL HCL (113 patients)
BENADRYL (113 patients)
BENADRYL ^ACHE^ (113 patients)
CARBOPLATIN (112 patients)
LUPRON (112 patients)
LEVOXYL (111 patients)
ESTRACE (110 patients)
WELLBUTRIN (110 patients)
COREG (109 patients)
PROCHLORPERAZINE (109 patients)
SENOKOT (109 patients)
ULTRAM (108 patients)
DEMEROL (107 patients)
SOMA (107 patients)
SPIRONOLACTONE (107 patients)
ZOLPIDEM (106 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for CALCITRAN B12


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about OSTEOPENIA and CALCITRAN B12, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking CALCITRAN B12, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in CALCITRAN B12. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CALCITRAN B12 experts. If you are a healthcare provider experienced in prescribing CALCITRAN B12, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use